Last reviewed · How we verify
Acquired thrombocytopenia
Approved treatments
- Solu-Cortef · Pfizer
- Cortifoam · Pfizer
- Cortone
- Celestone Soluspan
- Decadron · Generic (originally Merck)
- prednison · Wen Zhang
- Medrol · Generic (originally Upjohn/Pfizer)
Potent synthetic glucocorticoid with 5x hydrocortisone potency and minimal mineralocorticoid activity, used for severe inflammatory conditions. - Cortef · Generic (originally Merck/Upjohn)
- Rodinolone
- Deltasone · Generic (originally Schering)
- Betametasone
Betamethasone works by binding to the glucocorticoid receptor, which then triggers a series of downstream effects that reduce inflammation and suppress the immune system. - Cortisol · University of Zurich
- Prelone · Generic (originally Schering)
- prednisolon · Hannover Medical School
- Methylprednisolon · Leiden University Medical Center
Clinical guidelines
- FDA label — 2L
Dexamethasone is indicated for the treatment of idiopathic thrombocytopenic purpura in adults. - FDA label — any
no specific recommendation in the provided text - FDA label — any
no specific recommendation in the provided text - FDA label — any
no specific recommendation in the provided text - FDA label — any
no specific recommendation in the provided text - FDA label — any
no specific recommendation in the provided text - FDA label — any
no specific recommendation in the provided text - FDA label — any
no specific recommendation in the provided text - FDA label — any
no specific recommendation in the provided text - FDA label — 2L
Methylprednisolone can be used for the treatment of acquired (autoimmune) hemolytic anemia and select cases of secondary thrombocytopenia.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Acquired thrombocytopenia patent landscape — cliff calendar, originator estates, attackable patents
- Acquired thrombocytopenia treatment landscape brief
- Acquired thrombocytopenia treatment updates RSS
Frequently asked questions about Acquired thrombocytopenia
What drugs treat Acquired thrombocytopenia?
Tracked treatments include Solu-Cortef, Cortifoam, Cortone, Celestone Soluspan, Decadron, prednison, Medrol, Cortef.
What is the treatment for Acquired thrombocytopenia?
Standard treatment for Acquired thrombocytopenia includes Solu-Cortef, Cortifoam, Cortone, Celestone Soluspan, Decadron. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Acquired thrombocytopenia?
FDA label publishes guidelines for Acquired thrombocytopenia. 10 guideline references tracked.
Related
- Treatment landscape: Acquired thrombocytopenia patent cliff · Acquired thrombocytopenia CI report
- Treatment: Solu-Cortef · Pfizer
- Treatment: Cortifoam · Pfizer
- Treatment: Cortone
- Treatment: Celestone Soluspan
- Treatment: Decadron · Generic (originally Merck)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing